Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. OnKure Therapeutics Inc shares valued at $3,363,023 were sold by Cormorant Asset Management, LP on May 15 ’25. At $1.85 per share, Cormorant Asset Management, LP sold 1,813,439 shares. The insider’s holdings dropped to 0 shares worth approximately $0.0 following the completion of this transaction.
Also, ACORN BIOVENTURES, L.P. purchased 1,129,730 shares, netting a total of over 2,090,000 in proceeds. Following the buying of shares at $1.85 each, the insider now holds 1,129,730 shares.
Before that, ACORN BIOVENTURES, L.P. had added 270,270 shares to its account. In a trade valued at $500,000, the 10% Owner bought OnKure Therapeutics Inc shares for $1.85 each. Upon closing the transaction, the insider’s holdings increased to 270,270 shares, worth approximately $4.14 million.
As published in their initiating research note from Evercore ISI on April 30, 2025, OnKure Therapeutics Inc [OKUR] has been an Outperform. Analysts at Leerink Partners started covering the stock with ‘”an Outperform”‘ outlook in a report released in early December. As of October 10, 2024, Oppenheimer has initiated its “an Outperform” rating for OKUR. Earlier on December 15, 2023, Leerink Partners downgraded its rating. Their new recommendation was “a Market perform” for OKUR stock which previously was a “an Outperform”.
Analyzing OKUR Stock Performance
The stock’s lowest price that day was $2.4, but it reached a high of $2.56 in the same session. During the last five days, there has been a drop of approximately -14.49%. Over the course of the year, OnKure Therapeutics Inc shares have dropped approximately -71.86%. Shares of the company reached a 52-week high of $9.40 on 01/06/25 and a 52-week low of $1.70 on 05/13/25.
Support And Resistance Levels for OnKure Therapeutics Inc (OKUR)
According to the 24-hour chart, there is a support level at 2.35, which, if violated, would cause prices to drop to 2.27. In the upper region, resistance lies at 2.55. The next price resistance is at 2.67. RSI (Relative Strength Index) is 41.85 on the 14-day chart, showing neutral technical sentiment.
Is OnKure Therapeutics Inc subject to short interest?
Stocks of OnKure Therapeutics Inc saw a sharp steep in short interest on 2025-05-30 dropping by 43771.0 shares to 0.53 million. Data from Yahoo Finance shows that the short interest on 2025-04-30 was 0.57 million shares. A decline of -8.25% in short interest reflects a positive sentiment towards the stock. Despite the fact that short shares comprise just 1.73 of the overall float, the days-to-cover ratio (short ratio) decline to 1.73.
Which companies own the most shares of OnKure Therapeutics Inc (OKUR)?
In terms of OnKure Therapeutics Inc share price expectations, FactSet research, analysts set an average price target of 35 in the next 12 months, up nearly 1346.28% from the previous closing price of $2.42. Analysts anticipate OnKure Therapeutics Inc stock to reach 35 by 2025, with the lowest price target being 35.
